Militia Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Militia Capital Management's REGN Position: Q2 2026 in Review
Militia Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 33% in Q2 2026, buying an estimated $681K and bringing the position to 4,000 shares worth $2.49M. The position accounts for 0.07% of the portfolio, ranked #105.
Militia Capital Management first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. 1,303 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Militia Capital Management held 4,000 shares of Regeneron Pharmaceuticals worth $2.49M as of Q2 2026.
- Militia Capital Management bought 1,000 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $681K.
- Regeneron Pharmaceuticals made up 0.07% of Militia Capital Management's portfolio in Q2 2026, its #105 holding.
- Militia Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 1,303 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Militia Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.